0001225208-13-022269.txt : 20131024
0001225208-13-022269.hdr.sgml : 20131024
20131024174419
ACCESSION NUMBER: 0001225208-13-022269
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131023
FILED AS OF DATE: 20131024
DATE AS OF CHANGE: 20131024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEILAND JOHN H
CENTRAL INDEX KEY: 0001204663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 131168946
MAIL ADDRESS:
STREET 1: C/O C.R BARD INC
STREET 2: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2013-10-23
0000009892
BARD C R INC /NJ/
BCR
0001204663
WEILAND JOHN H
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
1
President and COO
Common Stock
2013-10-23
4
M
0
60210.0000
81.6950
A
204655.2900
D
Common Stock
2013-10-23
4
S
0
2500.0000
131.8321
D
202155.2900
D
Common Stock
2013-10-23
4
S
0
3732.0000
134.7575
D
198423.2900
D
Common Stock
2013-10-23
4
S
0
9278.0000
133.1899
D
189145.2900
D
Common Stock
2013-10-23
4
S
0
44700.0000
134.2361
D
144445.2900
D
Common Stock
5568.1450
I
401(k) Plan
Option (Right to Buy)
81.6950
2013-10-23
4
M
0
60210.0000
0.0000
D
2019-12-09
Common Stock
60210.0000
0.0000
D
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $131.59 to $132.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $134.63 to $135.25. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $132.6156 to $133.55. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $133.63 to $134.62. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options are Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan.
Options fully vested in accordance with schedule upon achievement of certain performance criteria.
Myra McGinley, Attorney-in-Fact
2013-10-24